Pasadena Angels
VC Fund
Altadena, United States
Pasadena Angels is a VC fund in Altadena focused on Software and Health Care. Entrepreneurial small businesses are major engines of job growth and key players in the commercialization of new technologies. However, most entrepreneurial ventures fail to achieve their goals. Among the most common reasons for such business failures are the inability to execute sound business plans and to access capital funding, particularly atcritical early stages of a company's development.Affiliated as Pasadena Angels, Inc., a nonprofit entity, the organization offers early-stage companies the opportunity to benefit from the knowledge of more than 100 experienced entrepreneurs, senior corporate executives, and skilled professionals from a variety of industries and venture capital affiliates.Approximately 80 companies from a broad range of industries are screened each year by Pasadena Angels members and are provided with invaluable counsel, including insights into developing business and financing strategies that are achievable and fundable. Companies also benefit from the group's feedback and the opportunity to connect with individuals who may offer more specialized expertise and advice.The organization's members provide up to $1 million in early-stage financing and seed money to emerging technology-based ventures located in Southern California. The group cooperates with other venture capital firms and angel investment groups to support companies that are raising between $1 to $5 million. Pasadena Angels members invest individually and directly, without any legal pooling of financial resources. The corporate entity, Pasadena Angels, Inc. does not invest or act as an investment agent in any manner.Pasadena Angels charges no fees and provides its services to companies which it believes have a significant potential for success and the potential to benefit from an association with the organization.
- Total investments:
- 58
- Last investment:
- Lead investor:
- 19%
- Fund size:
- $1.4M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Pasadena Angels invests in
Stages Pasadena Angels invests in
Countries Pasadena Angels invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 15 contacts → | |||
Round size
- Seed
- $700k–$3.5M
- Angel
- $600k–$2.6M
- Series A
- $1M–$3.4M
Investment Focus
Industry
- Software 10 (17%)
- Health Care 10 (17%)
- Biotechnology 8 (14%)
- SaaS 5 (9%)
- Mobile 5 (9%)
Stage
- Seed 20 (34%)
- Series A 11 (19%)
- Angel 4 (7%)
- Pre-Seed 4 (7%)
- Funding Round 4 (7%)
Country
- United States 49 (84%)
- Canada 1 (2%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Ling Hung
Member
|
Member | Total investments: 0 | Find email | |
Al Schneider
Member
|
Member | Total investments: 0 | Find email | |
Chris Wadden
Member
|
Member | Total investments: 0 | Find email | |
Dale Okuno
Member
|
Member | Total investments: 5 | Find email | |
|
Janice Orlando
Private Investor
|
Private Investor | Total investments: 0 | Find email | |
| See all 15 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Delta manufactures battery operated, medical refrigerators designed to store vaccines and blood products in any climate or environment. Delta is an innovator and manufacturer of ruggedized thermal systems, specializing in military applications. | Series A / Aug 04, 2025 | ||
| NuvOx Pharma develops a platform for drugs that upon intravenous injection, flow through the bloodstream arriving first at the lungs to pick up oxygen and finally to hypoxic tissue where they passively deliver the oxygen. Indications for NuvOx's drug include Stroke (Phase II ready), Oncology (Phase II ready), and Sickle Cell Crisis (Phase Ibready). | $7M / Convertible Note / Sep 27, 2023 | ||
| Essenvia is an online software to streamline pre and post-market workflow for medical device companies by streamlining plans or activities to market, improving cross-functional collaboration, and automating steps to manage initial and subsequent device modifications. | $4M / Seed / May 02, 2023 | ||
| HearHere is a travel audio app that shares the depth and diversity of stories - cultural, geographical, historical, and mythological. | $2M / Seed / Feb 28, 2022 | ||
| Everyset is the easiest platform for employers to on-board, pay, and insure project workforces. Workers instantly onboard and track payments with a profile portable between employers. To increase density between employers & workers, we are initially focused within entertainment. | $500K / Seed / May 01, 2021 | ||
| EventHub offers virtual expos, a sponsorship marketplace, and a management dashboard for event organizers. Its platform enables organizers to manage exhibitor applications, payments, paperwork, and logistics through a clean, intuitive dashboard that also enables batch updates and messaging. The company was founded in 2015 and is headquartered inSeattle, Washington. | Pre-Seed / Apr 22, 2021 | ||
| Medical device company dedicated to developing new technologies for skin cancer diagnostics | $1M / Seed / Mar 19, 2021 | ||
| Amsel Medical is a medical device company that develops mechanical surgical clamping technology for surgical and interventional procedures. The SCureClamp with Interdigitation Occlusion Technology (iDOTTM) from Amsel Medical is designed to easily and securely close vessels such as veins, arteries, and tubular structures. The anchoring feature ofthe SCureClamp keeps the implant in place and prevents slippage. Grasping enables doctors to occlude vessels of various sizes, types, and wall thicknesses. | $1.5M / Convertible Note / Jan 30, 2021 | ||
| Higher Ed Institutions do not prepare learners for sales consulting in technology pathways. Virtanza solves the problem by providing Universities, Colleges, and Employers the only scalable, sales and technology consulting career-relevant, end-to-end solution in the University system. Virtanza produces credentialed sales professionals and unmatchedspeed to employment. Virtanza’s private label program includes credit-bearing short courses, certificates, industry technical certifications, digital badges, and competency-based learning. | $1.4M / Seed / Nov 17, 2020 | ||
| Medical device company dedicated to developing new technologies for skin cancer diagnostics | Seed / Oct 26, 2020 | ||
| See all 58 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Pasadena Angels invest in?
Pasadena Angels invests primarily in Software, Health Care and Biotechnology startups, most often at Seed and Series A stage. Most of the 58 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Pasadena Angels invest in?
Pasadena Angels typically joins rounds of $700k–$3.5M at Seed, $600k–$2.6M at Angel and $1M–$3.4M at Series A. These are whole funding-round sizes, not Pasadena Angels's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Pasadena Angels took part in.
How do I contact Pasadena Angels?
Public channels for Pasadena Angels include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Pasadena Angels?
The team at Pasadena Angels includes Ling Hung (Member), Al Schneider (Member) and Chris Wadden (Member), among 15 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
